Effects of chronic treatment with two selective 5-HT2 antagonists on sleep in the rat
- 30 April 1993
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 44 (4) , 797-804
- https://doi.org/10.1016/0091-3057(93)90008-h
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Pharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT2 receptor antagonistBritish Journal of Pharmacology, 1992
- 5-Hydroxytryptamine Antagonistic Effects of ICI 169,369, ICI 170,809 and Methysergide in Human Temporal and Cerebral ArteriesBasic & Clinical Pharmacology & Toxicology, 1991
- Pharmacological studies in vivo with ICI 169,369, a chemically novel 5-HT2/5-HT1C receptor antagonistEuropean Journal of Pharmacology, 1990
- Effects of repeated ritanserin on middle-aged poor sleepersPsychopharmacology, 1989
- Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the ratPsychopharmacology, 1989
- Effect of ritanserin on sleep stages and sleep EEG in the ratEuropean Journal of Pharmacology, 1988
- In vitro studies with ICI 169,369, a chemically novel 5-HT antagonistEuropean Journal of Pharmacology, 1988
- The effects of chronic ritanserin treatment on sleep and the neuroendocrine response to l-tryptophanPsychopharmacology, 1987
- 5‐HT2 receptor characteristics in frontal cortex and 5‐HT2 receptor‐mediated head‐twitch behaviour following antidepressant treatment to miceBritish Journal of Pharmacology, 1984
- TrazodoneDrugs, 1981